Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for Behavioral Disturbance in FTD
NCT00127114Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Sep 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in frontotemporal dementia (FTD) comparing Amantadine with Placebo (2 arms). Primary endpoint: Frontal Behavioral Inventory, disinhibition subscale at 6 weeks. Planned start Sep 2005; status: withdrawn.
02
Drugs
amantadine
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT00127114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127114.